Cases

Lundbeck - Perform a budget impact analysis for the second class reimbursement submission of a long-acting injectable drug for the maintenance treatment of schizophrenia in Belgium.
Lundbeck asked hict for support in developing a budget impact analysis (BIA) for the reimbursement submission of Abilify Maintena®, a long-acting injectable drug for the maintenance treatment of...
Lundbeck - kosten-utiliteitsanalyse  budget impact analyse
The aim of the project was to support Lundbeck with the reimbursement submission for Selincro® (nalmefene), a new and innovative medicine to decrease the alcohol consumption of adult alcohol-...
Ezelstraat 69 | B- 8000 Brugge | Belgium | Phone: +32.50.33.33.40 | Fax: +32.50.33.33.39 | BTW BE 0866 039 556 | RPR/RPM Brugge | e-mail: info@hict.com